Grafix PL PRIME
Biological
Smith+Nephew, Inc.
Total Payments
$2.8M
Transactions
5,726
Doctors
2,388
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.2M | 244 | 0 |
| 2019 | $1.7M | 5,482 | 2,388 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.7M | 390 | 94.7% |
| Food and Beverage | $128,460 | 5,274 | 4.5% |
| Travel and Lodging | $22,007 | 62 | 0.8% |
Payments by Type
Research
$2.7M
390 transactions
General
$150,466
5,336 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension to Evaluate the Safety and Efficacy of GrafixPL PRIME for the Treatment of Chronic Venous Leg Ulcers | Smith+Nephew, Inc. | $2.2M | 1 |
| A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension to Evaluate the Safety and Efficacy of GrafixPL PRIME for the Treatment of Chronic Venous Leg Ulcers | Osiris Therapeutics Inc. | $349,521 | 0 |
| GrafixPL PRIME Evaluation | Smith+Nephew, Inc. | $60,089 | 1 |
| GrafixPL PRIME Evaluation | Osiris Therapeutics Inc. | $53,130 | 2 |
| Prospective, single-center, open-label study to evaluate the safety and efficacy of GrafixPL PRIME in patients with neuroischaemic ulcers | Smith+Nephew, Inc. | $49,250 | 0 |
Top Doctors Receiving Payments for Grafix PL PRIME — Page 96
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , DPM | Foot & Ankle Surgery | Noblesville, IN | $4.94 | 1 |
| , DPM | Foot & Ankle Surgery | Riverside, RI | $4.73 | 1 |
| , DPM | Foot & Ankle Surgery | Aberdeen, SD | $4.68 | 1 |
| , M.D | Orthopaedic Surgery | Oak Ridge, TN | $4.47 | 2 |
| , M.D | Orthopaedic Surgery | Oak Ridge, TN | $4.47 | 2 |
| , M.D | Orthopaedic Surgery | Oak Ridge, TN | $4.47 | 2 |
| , MD | Orthopaedic Surgery | Oak Ridge, TN | $4.47 | 2 |
| , D.P.M | Podiatrist | Brooklyn, NY | $3.45 | 1 |
| , D.P.M | Foot & Ankle Surgery | Brooklyn, NY | $3.43 | 1 |
| , MD | Surgery | Stoughton, MA | $3.16 | 1 |
| , DPM | Foot & Ankle Surgery | Lithonia, GA | $2.75 | 1 |
| , DPM | Foot & Ankle Surgery | Pittsburgh, PA | $1.58 | 1 |
| , M.D | Surgery | Cleveland, OH | $1.50 | 1 |
| , M.D | Plastic Surgery | Lancaster, PA | $1.16 | 1 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $2.4M
- Osiris Therapeutics Inc. $415,502
Product Information
- Type Biological
- Total Payments $2.8M
- Total Doctors 2,388
- Transactions 5,726
About Grafix PL PRIME
Grafix PL PRIME is a biological associated with $2.8M in payments to 2,388 healthcare providers, recorded across 5,726 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2019 to 2020. In 2020, $1.2M was paid across 244 transactions to 0 doctors.
The most common payment nature for Grafix PL PRIME is "Unspecified" ($2.7M, 94.7% of total).
Grafix PL PRIME is associated with 5 research studies, including "A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension to Evaluate the Safety and Efficacy of GrafixPL PRIME for the Treatment of Chronic Venous Leg Ulcers" ($2.2M).